All the latest breaking news on United States. Browse ibtimes archives of photos, videos and articles on United States.

Trusted Messengers' exhibit, which opens Saturday, will include materials from vaccine development at Penn's Weissman Lab.

The text is printed on the ham bag in festive red and green lettering, with a Christmas tree replacing the first “A.” (JTA) — A ham bag has been removed from Australia’s Kmart website ...

Bernstein lowered the firm’s price target on Pfizer (PFE) to $30 from $32 and keeps a Market Perform rating on the shares. The firm notes Pfizer reported Q4 earnings reflecting stabilized COVID ...

Bernstein analyst Courtney Breen maintained a Hold rating on Pfizer (PFE – Research Report) yesterday and set a price target of $30.00. The company’s shares closed yesterday at $26.65.

Patrizia Cavazzoni, a former high-ranking Food and Drug Administration official who oversaw a large portion of the agency’s drug review work, will join Pfizer as its next chief medical officer, the ...

Pfizer is pulling further away from the gene therapy field with its decision to discontinue hemophilia product Beqvez. The New York pharma is ending global development and commercialization of ...

Ever since From season 3 accelerated to a riveting finale at the end of last year, fans have been clamouring for a season 4. Well, there's both good and bad news on this front. While, thankfully ...

Pfizer will no longer develop and commercialize its hemophilia B gene therapy Beqvez across all of its global markets, according to multiple media reports Thursday. In a statement to Nikkei Asia, the ...

At February’s Nicer Tuesdays, the Dutch design studio joined us to share the origins of their playful, analogue approach. Giving us a peek behind the scenes into the objects and ideas that have ...

At the time I argued that Pfizer's projected EPS growth and anticipated rise in EBITDA margins suggested a positive trajectory for the stock price, so seeing a 20%+ upside from those levels ...

Pfiz­er CEO Al­bert Bourla said its man­u­fac­tur­ing busi­ness could be vul­ner­a­ble to Pres­i­dent Don­ald Trump’s tar­iffs in Eu­rope as the phar­ma gi­ant has “sig­nif ...